Nausea and Vomiting
Explore how medical cannabis can help manage nausea and vomiting, including chemotherapy-induced nausea. Review FDA-approved cannabinoid antiemetics and dosing guidance.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Cannabis is not FDA-approved for most conditions. Always consult a qualified healthcare provider before starting any cannabis-based treatment. Do not use this information to self-diagnose or replace professional medical care.
Overview
Nausea and vomiting are among the most debilitating symptoms experienced by patients undergoing chemotherapy, radiation therapy, and those with conditions such as gastroparesis, cyclic vomiting syndrome, and hyperemesis gravidarum. Chemotherapy-induced nausea and vomiting (CINV) remains a significant clinical challenge despite modern antiemetic regimens. The vomiting reflex is coordinated by the nucleus tractus solitarius and the chemoreceptor trigger zone in the brainstem, integrating inputs from the vagus nerve, vestibular system, and higher cortical centers. First-line antiemetics include 5-HT3 antagonists (ondansetron), NK1 antagonists (aprepitant), and corticosteroids. Cannabinoid antiemetics represent one of the most well-established therapeutic applications of medical cannabis, with two synthetic cannabinoids (dronabinol and nabilone) holding FDA approval for CINV since the 1980s. This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any cannabis-based treatment.
How Cannabis Helps
THC exerts potent antiemetic effects through CB1 receptor activation in the dorsal vagal complex of the brainstem, where emetic signals are processed. CB1 activation inhibits serotonin release from enterochromaffin cells in the gut and reduces signaling in the chemoreceptor trigger zone. CBD contributes antiemetic effects through indirect 5-HT1A serotonin receptor agonism, operating through a distinct mechanism from THC. THCA (tetrahydrocannabinolic acid), the raw precursor to THC, has shown antiemetic properties in preclinical models at lower doses than THC without psychoactive effects. The combination of THC and CBD may provide broader antiemetic coverage than either cannabinoid alone, addressing both acute and delayed nausea phases.
Recommended Cannabinoids
THC
Primary antiemetic cannabinoid acting on CB1 receptors in the brainstem's emetic center. FDA-approved as dronabinol for chemotherapy-induced nausea since 1985.
THCA
Raw, non-psychoactive precursor to THC that has demonstrated antiemetic effects in preclinical studies at doses lower than those required for THC.
CBD
Provides complementary antiemetic action through 5-HT1A serotonin receptor agonism, particularly effective for anticipatory nausea.
Recommended Consumption Methods
- 1Dronabinol (Marinol) or nabilone (Cesamet) as prescribed for CINV
- 2Sublingual THC tinctures for rapid-onset nausea relief
- 3Low-temperature vaporization when oral administration is not tolerated
- 4THCA tinctures (raw cannabis extracts) for those seeking non-psychoactive options
- 5THC:CBD combination products for comprehensive antiemetic coverage
Dosage Guidance
Dronabinol for CINV is typically dosed at 5mg/m2 given 1-3 hours before chemotherapy and every 2-4 hours after, up to 4-6 doses per day. Nabilone is dosed at 1-2mg twice daily during chemotherapy cycles. For whole-plant cannabis, start with 2.5-5mg THC taken 30-60 minutes before anticipated nausea triggers. CBD at 10-20mg may be added for anticipatory nausea. When vomiting prevents oral intake, inhalation offers an alternative route. Low doses are often sufficient since the antiemetic threshold for THC is generally lower than the dose required for significant psychoactive effects.
Recommended Strains
Strains commonly associated with nausea and vomiting relief, based on reported medical uses.
Research Summary
A 2015 systematic review in BMJ found that cannabinoids were significantly more effective than placebo and comparable to conventional antiemetics for CINV, with patients reporting preference for cannabinoids. The FDA approved dronabinol in 1985 and nabilone in 1985 for CINV refractory to conventional antiemetics, representing the earliest medical cannabis approvals. A 2020 Australian randomized controlled trial published in Annals of Oncology found that oral THC:CBD significantly improved CINV control compared to placebo when added to standard antiemetics. A Cochrane review of 23 trials involving 1,326 participants confirmed that cannabinoids were more effective than active comparators or placebo for CINV, though side effects were more frequent.
Side Effects & Risks
- ⚠Dizziness, euphoria, and dysphoria are common THC-related side effects
- ⚠Paradoxical cannabinoid hyperemesis syndrome (CHS) with chronic heavy use
- ⚠Hypotension and tachycardia, particularly in dehydrated patients
- ⚠Cognitive impairment may compound chemotherapy-related brain fog
- ⚠Drug interactions with other antiemetics and chemotherapy agents
Frequently Asked Questions
Are there FDA-approved cannabis medications for nausea?
Yes. Dronabinol (Marinol/Syndros) and nabilone (Cesamet) are FDA-approved synthetic cannabinoids for chemotherapy-induced nausea and vomiting. Dronabinol is also approved for AIDS-related anorexia. These represent some of the earliest and most established medical uses of cannabinoids.
What is cannabinoid hyperemesis syndrome?
Cannabinoid hyperemesis syndrome (CHS) is a paradoxical condition where chronic, heavy cannabis use triggers cyclical episodes of severe nausea, vomiting, and abdominal pain. Hot showers temporarily relieve symptoms. The only definitive treatment is complete cannabis cessation. CHS is rare but increasingly recognized.
Can cannabis help with morning sickness?
While some women report using cannabis for pregnancy-related nausea, major medical organizations including ACOG strongly advise against cannabis use during pregnancy due to potential risks to fetal development, including low birth weight and neurodevelopmental effects. Safer antiemetic alternatives exist for pregnancy.